Outcome in Psychogenic Nonepileptic Seizures: 1 to 10-Year Follow-up in 164 Patients
Ann Neurol 53:305-311,285, Reuber,M.,et al, 2003
Practice Parameter: Temporal Lobe and Localized Neocortical Resections for Epilepsy
Neurol 60:538-547, Engel,J.,et al, 2003
Intranasal Sumatriptan in Cluster Headache
Neurol 60:630-633, van Vliet,J.A.,et al, 2003
Major Malformations in Offspring of Women with Epilepsy
Neurol 60:575-579, Kaaja,E.,et al, 2003
Early Outcome of Carotid Angioplasty and Stenting With and Without Cerebral Protection Devices
Stroke 34:813, Kastrup,A.,et al, 2003
Use of a Field-to-Stroke Center Helicopter Transport Program to Extend Thrombolytic Therapy to Rural Residents
Stroke 34:729, Silliman,S.L.,et al, 2003
Telemedicine for Acute Stroke
Stroke 34:725, LaMonte,M.P.,et al, 2003
Early Major Ischemic Changes on Computed Tomography Should Preclude Use of Tissue Plaminogen Activator
Stroke 34:820-821,822, von Kummer,R., 2003
Early Major Ischemic Changes on Computed Tomography Should Not Preclude Use of Tissue Plasminogen Activator
Stroke 34:821-822,822, Lyden,P.,et al, 2003
[123I]b-CIT SPECT is a Useful Method for Monitoring Dopaminergic Degeneration in Early Stage Parkinson's Disease
JNNP 74:294-298,287, Winogrodzka,A.,et al, 2003
Neuropsychological and Quality of Life Outcomes 12 Months After Unilateral Thalamic Stimulation for Essential Tremor
JNNP 74:305-311, Fields,J.A.,et al, 2003
Oral Anticoagulants Versus Antiplatelet Therapy for Preventing Further Vascular Events After Transient Ischemic Attack or Minor Stroke of Presumed Arterial Origin
Stroke 34:234-235, Algra,A.,et al, 2003
Bilateral Vertebral Artery Occlusion Resulting from Giant Cell Arteritis: Report of 3 Cases and Review of the Literature
Medicine 82:1-12, Ruegg,S.,et al, 2003
Audiovestibular Manifestations in Giant Cell Arteritis: A Prospective Study
Medicine 82:13-26, Amor-Dorado,J.C.,et al, 2003
Prospective Evaluation of Neurological Complications After Allogeneic Bone Marrow Transplantation
Neurol 60:842-848, Sostak,P.,et al, 2003
Vestibular Neuritis
NEJM 348:1027-1032, Baloh,R.W., 2003
Ten Most Commonly Asked Questions About the Psychiatric Aspects of Parkinson's Disease
The Neurologist 9:50-56, Reich,S.G. & Marsh,L., 2003
Treatment of Wilson Disease With Ammonium Tetrathiomolybdate, III. Initial Therapy in a Total of 55 Neurologically Affected Patients and Follow-up With Zinc Therapy
Arch Neurol 60:379-385, Brewer,G.J.,et al, 2003
Insights Into the Diagnosis and Treatment of Lysosomal Storage Diseases
Arch Neurol 60:322-328, Wegner,D.A.,et al, 2003
Prophylactic Treatment of Migraine With an Angiotnesin II Receptor Blocker
JAMA 289:65-69, Tronvik,E.,et al, 2003
Drug Treatments for Eye Movement Disorders
JNNP 74:1-4, Leigh,R.J., &Tomsak,R.L., 2003
Determination of Lipid Profiles and Use of Statins in Patients With Ischemic Stroke or Transient Ischemic Attack
Stroke 34:105-110, Lalouschek,W.,et al, 2003
A Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
NEJM 348:14-23, Miller,D.H.,et al, 2003
Analysis of Pooled Data From the Randomised Controlled Trials of Endarterectomy for Symptomatic Carotid Stenosis
Lancet 361:107-116, Rothwell,P.M.,et al, 2003
Antivonvulsants for Creutzfeldt-Jakob Disease?
Lancet 361:224, Fioel,A.,et al, 2003
Central Nervous System Paracoccidioidomycosis: Imaging Findings in 17 Cases
J Comput Assist Tomogr 27:12-17, Gasparetto,E.L.,et al, 2003
Rapidly Reversible Dementia
Lancet 361:392, Bernstein,R.,et al, 2003
Hypnic Headache, Clinical Features, Pathophysiology, and Treatment
Neurol 60:905-909, Evers,S.&Goadsby,P.J., 2003
Painful Sensory Neuropathy
NEJM 348:1243-1255, Mendell,J.R.&Sahenk,Z., 2003
Bilateral Anterior Toxic Optic Neuropathy and the Use of Infliximab
BMJ 326:579, ten Tusscher,M.P.M.,et al, 2003
Oral Opioid Therapy for Chronic Peripheral and Central Neuropathic Pain
NEJM 348:1223-1232, 1279, Rowbotham,M.C.,et al, 2003
Chronic Low Back Pain
BMJ 326:535, Samanta,J.,et al, 2003
Neurological Aspects of Taste Disorders
Arch Neurol 60: 667-671, Heckmann,J.G.,et al, 2003
Stem Cells and Neurological Disease
JNNP 74:553-557, Barker,R.A.,et al, 2003
Randomized Trial of Pallidotomy Versus Medical Therapy for Parkinson's Disease
Ann Neurol 53:558-569, Vitek,J.L.,et al, 2003
Management of Drug and Alcohol Withdrawal
NEJM 348:1786-1795, Kosten,T.R. &O'Connor,P.G., 2003
Pacemaker Therapy for Prevention of Syncope in Patients with Recurrent Severe Vasovagal Syncope
JAMA 289:2224-2229,2272, Connolly,S.J.,et al, 2003
Vertebral Artery Origin Angioplasty and Primary Stenting: Safety and Restenosis Rates in a Prospective Series
JNNP 74:586-590, Cloud,G.C.,et al, 2003
West Nile Encephalitis
BMJ 326:865-869, Solomon,T.,et al, 2003
Status Epilepticus: A Review of Different Syndromes, Their Current Evaluation, and Treatment
The Neurologist 9:61-76, Gaitanis,J.N. &Drislane,F.W., 2003
Evidence for Widespread Axonal Damage at the Earliest Clinical Stage of Multiple Sclerosis
Brain 126:433-437, Filippi,M.,et al, 2003
Outcome of Trigeminal Nerve Section in the Treatment of Chronic Cluster Headache
Neurol 60:1360-1362, Jarrar,R.G.,et al, 2003
Treatment of Postherpetic Neuralgia
Neurol 60:E6-E7, Lovitt,S., 2003
Why Should Neuroradiologist Study Patients with Smell Loss?
AJNR 24:556-557, Levy,L.M.&Henkin,R.I., 2003
Amnesia, Cerebral Atrophy, and Autoimmunity
Lancet 361:1266, Schott,J.M., et al, 2003
Treatment of Herpes Zoster and Postherpetic Neuralgia
BMJ 326:748-750, Johnson,R.W. &Dworkin,R.H., 2003
Neurologic Complications of Anthrax
Arch Neurol 60:483-488, Meyer,M.A., 2003
Why Headache Treatment Fails
Neurol 60:1064-1070, Lipton,R.B.,et al, 2003
Cerebral Venous Thrombosis
Neurol 60:1175-1178, Cakmak,S.,et al, 2003
DHEA Treatment of Alzheimer's Disease
Neurol 60:1071-1076,1060, Wolkowitz,O.M.,et al, 2003